BRIEF-FDA accepts Novartis submission of biosimilar version of Humira By: Reuters: Company News January 16, 2018 at 01:06 AM EST * SANDOZ REGULATORY SUBMISSION FOR PROPOSED BIOSIMILAR ADALIMUMAB ACCEPTED BY FDA Read More >> Related Stocks: AbbVie Novan Inc